EU Clinical Trial Regulation to Take Effect on 31 January 2022 | Allen & Overy LLP jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Six-month countdown to go-live for the Clinical newsincyprus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsincyprus.com Daily Mail and Mail on Sunday newspapers.
To print this article, all you need is to be registered or login on Mondaq.com.
Earlier this year, industry became more intimately familiar with
the clinical trials reporting requirements in the U.S. when, on
April 27, the
U.S. Food and Drug Administration sent a notice of
noncompliance to Acceleron
Pharma Inc. identifying the company s failure to submit
study results from a November 2017 trial that tested the efficacy
of dalantercept and axitinib, proposed treatments for renal cell
carcinoma.
As sponsors and principal investigators seek to learn from the
Acceleron example, it is important for industry to consider
reporting requirements not just in the U.S., but also for
ADVERTISEMENT
What To Watch As EU Clinical Trial Compliance Changes
Law360 (July 13, 2021, 6:47 PM EDT) Earlier this year, industry became more intimately familiar with the clinical trials reporting requirements in the U.S. when, on April 27, the U.S. Food and Drug Administration sent a notice of noncompliance to Acceleron Pharma Inc. identifying the company s failure to submit study results from a November 2017 trial that tested the efficacy of dalantercept and axitinib, proposed treatments for renal cell carcinoma.
As sponsors and principal investigators seek to learn from the Acceleron example, it is important for industry to consider reporting requirements not just in the U.S., but also for the European Union given the Clinical Trials Regulation, which,.